1. 1991.3- 1997.2 서울대학교 의과대학 의학과 2. 2000.3-2002.2 서울대학교 의과대학원 의학석사 3. 2002.3-2004.2 서울대학교 의과대학원 의학박사 4. 2003.3-2006.2 서울대학교 보라매병원 내과 (혈액종양내과) 조교수 5. 2006.3-2012.2 서울대학교병원 내과 (혈액종양내과) 조교수 6. 2011.9-2012.8 미국 텍사스의과대학 M.D. Anderson Cancer Center, 객원 조교수 7. 2012.3-2016.8 서울대학교 병원 내과 (혈액종양내과) 부교수 8. 2016.9- 현재 서울대학교병원 내과 (혈액종양내과) 교수 Education and career 1. Mar. 1991-Feb. 1993 Premedical School, Seoul National University, Seoul, Korea 2. Mar. 1993-Feb. 1997 College of Medicine, Seoul National University, Seoul, KoreaWith honor and scholarship Graduated first on the list 3. Mar. 2000-Feb. 2002 Course of Degree of Master in Medicine (Internal Medicine), Seoul National University College of Medicine, Seoul, Korea 4. Mar. 2002-Feb. 2004 Course of Doctor of Philosophy in Medicine (Internal Medicine), Seoul National University College of Medicine, Seoul, Korea 5. Mar. 1997-Feb. 1998 Internship course, Seoul National University Hospital 6. Mar. 1998- Feb. 2002 Residency course at Departmen

1. Oh DY, Bang YJ. HER2-targeted therapies - a role beyond breast cancer. Nat Rev Clin Oncol. 2020 Jan;17(1):33-48 2. Jin MH, Oh DY. ATM in DNA repair in cancer. Pharmacol Ther. 2019 Jul 9:107391. 3. Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. N Engl J Med. 2019 Jul 25;381(4):317-327. 4. Park C, Keam B, Yoon SH, Ock CY, Choi SM, Kim M, Park YS, Kim TM, Oh DY, Kim DW, Kim YW, Heo DS, Bang YJ. Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis. ESMO Open. 2019 Nov 28;4(6):e000575. 5. Jin MH, Nam AR, Park JE, Bang JH, Bang YJ, Oh DY. Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.